Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition).

IF 4.1 2区医学 Q1 DERMATOLOGY Mycoses Pub Date : 2024-09-01 DOI:10.1111/myc.13785

Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu

{"title":"Chinese expert consensus on management of antifungal-resistant dermatophytoses (2024 edition).","authors":"Guanzhao Liang, Xiaofang Li, Ruoyu Li, Hai Wen, Jun Gu, Yuping Ran, Liyan Xi, Fuqiu Li, Qiangqiang Zhang, Cunwei Cao, Peiying Feng, Meng Fu, Yanping Jiang, Shanshan Li, Hongfang Liu, Zehu Liu, Xuelian Lv, Paride Abliz, Weihua Pan, Hong Sang, Xiaodong She, Dongmei Shi, Zhongsheng Tong, Aiping Wang, Ling Wang, Yuanyuan Xiao, Jie Yang, Lianjuan Yang, Jin Yu, Ping Zhan, Siping Zhang, Yu Zhang, Hongmei Zhu, Min Zhu, Ge Song, Xue Kong, Weida Liu","doi":"10.1111/myc.13785","DOIUrl":null,"url":null,"abstract":"<p><p>Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.</p>","PeriodicalId":18797,"journal":{"name":"Mycoses","volume":"67 9","pages":"e13785"},"PeriodicalIF":4.1000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mycoses","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/myc.13785","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Antifungal-resistant dermatophytes (ARD) infection is a hotspot issue in clinical microbiology and the dermatology field. Trichophyton indotineae as the dominant species of dermatophyte with terbinafine-resistance or multidrug resistance, is easy to be missed detection clinically, which brings severe challenges to diagnosis and treatment. ARD infection cases have emerged in China, and it predicts a risk of transmission among human. Based on the existing medical evidence and research data, the Mycology Group of Combination of Traditional and Western Medicine Dermatology and Chinese Antifungal⁃Resistant Dermatophytoses Expert Consensus Group organized experts to make consensus on the management of the infection. Here, the consensus formulated diagnosis and treatment recommendations, to raise attention to dermatophytes drug resistance problem, and expect to provide reference information for the clinical diagnosis, treatment, prevention and control.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

中国抗真菌皮癣菌管理专家共识（2024 年版）》。

抗真菌耐药皮癣菌（ARD）感染是临床微生物学和皮肤病学领域的热点问题。indotineae 毛癣菌作为皮癣菌中具有特比萘芬耐药性或多药耐药性的优势菌种，临床上容易漏检，给诊断和治疗带来严峻挑战。ARD感染病例已在中国出现，并预示着其在人群中传播的风险。基于现有的医学证据和研究资料，中西医结合皮肤科真菌学组和中国抗真菌⁃耐药皮癣专家共识组组织专家对该感染的处理达成共识。在此，共识制定了诊疗建议，以唤起人们对皮真菌耐药问题的重视，并期望为临床诊断、治疗和防控提供参考信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Mycoses 医学-皮肤病学

CiteScore

10.00

自引率

8.20%

发文量

143

审稿时长

6-12 weeks

期刊介绍： The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi. Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.